CALL US: 1-855-483-4325

Keywords

ibrutinib, lenalidomide, maximum tolerated doses, refractory non-GCB DLBCL, relapsed

Principal Investigator

Nam H Dang, M.D.

Department

HEMATOLOGY AND ONCOLOGY

Contact Information

nam.dang@medicine.ufl.edu
3522737832

Be an Informed Participant

Before deciding to participate in a research study, take time to learn about clinical research, how it's conducted and your rights as a research participant. Following are some helpful resources from independent sources. Always remember that a clinical research study is research, not treatment.

Know Who to Contact

  • Eligibility: For questions about a specific study and who is eligible to participate, call or email the contact person listed for that study.
  • Your Rights: For questions about your rights as a research participant, contact the UF Institutional Review Boards at 352-273-9600.
  • Feedback: For general questions or feedback about study listings, email the UF Clinical and Translational Science Institute at CTSI-Studies-L@lists.ufl.edu.

Other Resources

  • ResearchMatch.org: Join a national registry of volunteers willing to be contacted about research studies.

For Research Teams